Corbus Pharmaceuticals, Inc.

109 articles about Corbus Pharmaceuticals, Inc.

• Did Corbus Investors Get Thrown Off By A Red Herring?

  4/11/2017

• Corbus To Commence Single Phase III Study Of Anabasum For Treatment Of Systemic Sclerosis Following Guidance Received From Successful End-Of-Phase II Meeting With FDA

  4/5/2017

• Tiny Massachusetts Phenom Corbus Plunges Despite Reporting Positive Phase II CF Data

  3/30/2017

• The Hype Behind Massachusetts Biotech Corbus' Sole Pipeline Drug

  3/20/2017

• Corbus To Present Gene Expression Data From Recent Phase II Systemic Sclerosis Study Demonstrating JBT-101 Inhibits Inflammation And Fibrosis Pathways

  3/8/2017

• Corbus Announces $27.2 Million Registered Direct Offering

  2/28/2017

• Corbus Announces Preclinical Data Demonstrating JBT-101 Reduces Inflammation In Alveolar Macrophages From Cystic Fibrosis Patients

  2/24/2017

• Why Corbus' Stock Rocketed 412% Upwards in 2016

  1/17/2017

• Corbus Release: Pharma Receives Orphan Designation For JBT-101 For The Treatment Of Systemic Sclerosis In The European Union

  1/17/2017

• Why Massachusetts’ Corbus Keeps a ‘Remarkably Young Staff’—And How it Plans to Double Headcount

  12/9/2016

• Corbus To Ring The Nasdaq Stock Market Closing Bell

  12/6/2016

• Little Corbus Gains Close to $180 Million in Market Cap on Mid-Stage Systemic Sclerosis Data

  11/14/2016

• Unnamed Fund Manager With Reliable Track Record Says High-Flying Corbus is About to Crash

  10/25/2016

• Corbus Reports 2016 Second Quarter Financial Results And Provides Business Update

  8/15/2016

• Corbus Completes $15 Million Registered Direct Offering

  6/15/2016

• Corbus Announces $15 Million Registered Direct Offering

  6/10/2016

• Corbus Release: Non-Deal Road Show Adds Confidence To Our Bullish Thesis

  6/2/2016

• Corbus Expands Clinical Development Of Resunab With Phase 2 Trial For The Treatment Of Systemic Lupus Erythematosus

  3/8/2016

• Corbus To Present At Biotech Showcase On January 12, 2016

  1/5/2016

• Corbus To Present At Two Upcoming Investor Conferences In December 2015

  11/24/2015